Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)

被引:0
|
作者
Fabi, A
De Marco, S
Barduagni, M
Gamucci, T
Cortesi, E
De Marinis, F
Ferraresi, V
Saltarelli, R
Gabriele, A
Accettura, C
Cognetti, F
机构
[1] Regina Elena Canc Inst, Rome, Italy
[2] ASL RMH, Rome, Italy
[3] Umberto I Hosp, Frosinone, Italy
[4] Umberto I Univ La Sapienza, Rome, Italy
[5] Forlanini Hosp, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A16
引用
收藏
页码:4 / 4
页数:1
相关论文
共 50 条
  • [1] Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy
    Azim, Hatem A., Jr.
    Scarfone, Giovanna
    Peccatori, Fedro A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 560
  • [2] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [3] Weekly paclitaxel and carboplatin chemotherapy with concomitant radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC)
    Spasova, Irena
    Pajdhauser, Roman
    Skacel, Zdenek
    Marel, Miloslav
    Musil, Jaromir
    CHEST, 2006, 130 (04) : 233S - 233S
  • [4] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [5] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [6] Weekly paclitaxel in advanced non-small cell lung cancer
    Chang, AYC
    Rubins, J
    Asbury, R
    Boros, L
    Hui, LF
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 10 - 13
  • [7] Concurrent chemoradiotherapy with paclitaxel and carboplatin for locoregionally advanced non-small cell lung cancer (NSCLC)
    Kaplanova, J.
    Tomiskova, M.
    Babickova, L.
    Kadlec, B.
    Slampa, P.
    Skrickova, J.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [8] Review of paclitaxel/carboplatin in advanced non-small cell lung cancer
    Bonomi, P
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 55 - 59
  • [9] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [10] PGG β-GLUCAN WITH CARBOPLATIN, PACLITAXEL AND CETUXIMAB FOR CHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Schneller, F.
    Thomas, M.
    Sadjadian, P.
    Kollmeier, J.
    Bose, N.
    Antonysamy, M.
    Patchen, M.
    Lowe, J.
    Huhn, R. D.
    Mattson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S40 - S41